A study demonstrated that CD44 enhanced PD-L1 expression partly by the cleaved intracytoplasmic domain of CD44 bound to the consensus CD44-ICD binding site on the regulatory region of the PD-L1 locus in NSCLC (82). Here, CD274 is linked to non-small cell lung carcinoma.